Bio
Kavita Iyer graduated with a Bachelor of Pharmacy from the University of Mumbai. Subsequently she earned her PhD in Medicinal Chemistry from Virginia Commonwealth University, VCU. She further pursued a post-doctoral fellowship in the Department of Physiology and Biophysics at VCU where she was trained as a structural biologist and subsequently worked as a Research Scientist. While at CAS, Kavita has worked on a wide range of topics including immuno-oncology, CRISPR therapeutics, rare diseases, and nano biosensors in Life Sciences as well as covalent inhibitors and PROTACs in Medicinal Chemistry.
생명공학
Could xenotransplantation solve organ transplant shortages?
With the advent of genetic editing technology, researchers are increasingly able to address immuno-compatibility issues, getting closer to making organs and tissues available for transplant from animal donors to human recipients.
약물 발견
PPI inhibitors show promise in cancer trials
Small molecule PPI inhibitors are on the brink of improving cancer treatments
이머징 사이언스
동시 발생 개념이 면역종양학에서 새로운 연구 방향을 제시합니다
개념 동시 발생 분석은 과학적 발견에서 최신 아이디어를 보여주고 면역종양학의 혁신을 주도합니다.
약물 발견
PROTACs revolutionize small molecule drugs
PROTACs are driving small molecule drug development to treat cancer, neurodegenerative diseases and more
생명공학
Webinar: Big data insights in the quest to cure cancer
Experts discuss emerging trends in immuno-oncology, data challenges, and opportunities ahead for cancer researchers.
약물 발견
면역 치료 및 암 분야의 새로운 트렌드
이 기사에서 종양면역학 간행물과 해당 연구 영역의 새로운 트렌드를 알아보고 새로운 기회와 과제를 확인해 보십시오.